More than 10 years of innovation

Cardiabase has seen constant growth since its foundation in 1999

Based in Nancy (France), Cardiabase is a cardiac core lab specialized in the processing, analysis and reporting of cardiac safety and efficacy data since 1999.

As the result of continuous research and innovation Cardiabase is today a mature and reputable organisation that provides services to more than 30 international pharmaceutical companies, device manufacturers and biotechnology companies.

Our multidisciplinary team has continually enhanced the methodology and technology for capturing and managing cardiac safety data offering sponsors innovative and cost-effective solutions.

As a testimony to the quality of our services, the proportion of repeat business is extremely high between 80% and 90% of the annual volume while the number of new sponsors continues to grow.

Cardiabase is involved in a growing number of Phase III multinational trials thanks to our constant efforts at innovating and investing in state-of-the-art technologies to provide high quality logistical and support services.

Key advantages:
 

Over 100 projects have been conducted in 2009, including 12 thorough QT studies.

Over 30 employees work at Cardiabase, assisted by 15 cardiologists.